Greenwich LifeSciences (GLSI) EPS (Basic) (2019 - 2026)

Greenwich LifeSciences (GLSI) has 7 years of EPS (Basic) data on file, last reported at -$1.27 in Q4 2025.

• Quarterly EPS (Basic) fell 1.43% year-over-year to -$1.27 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$2.12 (down 14.47% YoY) and the FY2025 annual result came in at -$2.12, down 14.47% from the prior year.
• EPS (Basic) fell to -$1.27 in Q4 2025, from -$0.3 in the prior quarter.
• In the past five years, EPS (Basic) ranged from a high of -$0.05 in Q1 2021 to a low of -$1.27 in Q4 2025.
• A 5-year average of -$0.32 and a median of -$0.2 in 2024 frame the typical range for EPS (Basic).
• The widest YoY moves for EPS (Basic): up 0.7% in 2022, down 223.27% in 2022.
• Tracing GLSI's EPS (Basic) over 5 years: stood at -$0.3 in 2021, then sank by 53.34% to -$0.46 in 2022, then dropped by 22.96% to -$0.56 in 2023, then slumped by 121.96% to -$1.25 in 2024, then retreated by 1.43% to -$1.27 in 2025.
• The last three EPS (Basic) figures came in at -$1.27 (Q4 2025), -$0.3 (Q3 2025), and -$0.3 (Q2 2025), per Business Quant data.